Oncotarget

Research Papers:

Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer

Shui-Yi Liu, Xiao-Yi Li, Wei-Qun Chen, Hui Hu, Bo Luo, Yu-Xiang Shi, Tang-Wei Wu, Yong Li, Qing-Zhi Kong, Hong-Da Lu and Zhong-Xin Lu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:61731-61741. https://doi.org/10.18632/oncotarget.18686

Metrics: PDF 744 views  |   HTML 1249 views  |   ?  


Abstract

Shui-Yi Liu1,2,*, Xiao-Yi Li1,*, Wei-Qun Chen1,2,3,*, Hui Hu1, Bo Luo6, Yu-Xiang Shi6, Tang-Wei Wu1, Yong Li1,7, Qing-Zhi Kong2,3,4,5, Hong-Da Lu2,3,4,5 and Zhong-Xin Lu1,2,3,4

1Department of Medical Laboratory, Central Hospital of Wuhan, Wuhan 430014, China

2Cancer Research Institute of Wuhan, Wuhan 430014, China

3Department of Central Laboratory, Central Hospital of Wuhan, Wuhan 430014, China

4Key Laboratory for Molecular Diagnosis of Hubei Province, Central Hospital of Wuhan, Wuhan 430014, China

5Department of Oncology, Central Hospital of Wuhan, Wuhan 430014, China

6Department of Pathology, Central Hospital of Wuhan, Wuhan 430014, China

7Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA

*These authors have contributed equally to this work

Correspondence to:

Zhong-Xin Lu, email: lzx71@yahoo.com

Hong-Da Lu, email: phlonda@163.com

Keywords: miR-145, methylation, breast cancer, ANGPT2, migration and invasion

Received: November 04, 2016    Accepted: May 12, 2017    Published: June 27, 2017

ABSTRACT

miR-145 has been implicated in the progression of breast cancer. Here, we report that its expression is decreased in breast cancer specimens and cell lines and that this low level of expression is associated with DNA methylation of its gene, MIR145. Methylation of MIR145 has previously been correlated with cell migration and invasion, both in vivo and in vitro. We found that demethylation of MIR145 reactivates miR-145 and contributes to the anti-cancer properties of 5-aza-2′-deoxyazacytidine (5-AzaC). Therefore, miR-145 is a potentially valuable biomarker for breast cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18686